UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
Turning Point Brands
TPB
$1.74B
| $390K | ﹤0.01% |
12,138
-10,698
| -47% | -$331K |
|
5177
FibroBiologics
FBLG
$6.5M
| $389K | ﹤0.01% |
3,903
+3,902
| +390,200% | +$744K |
|
|
ETRN
5178
PUT
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $389K | ﹤0.01% |
30,000
| – | – |
|
5179
Alignment Healthcare
ALHC
$2.98B
| $387K | ﹤0.01% |
49,517
-37,685
| -43% | -$246K |
|
5180
Stride
LRN
$3.43B
| $387K | ﹤0.01% |
5,492
-41,757
| -88% | -$2.78M |
|
5181
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$208M
| $387K | ﹤0.01% |
6,410
-2,095
| -25% | -$132K |
|
5182
Invesco KBW High Dividend Yield Financial ETF
KBWD
$427M
| $387K | ﹤0.01% |
25,709
-9,510
| -27% | -$145K |
|
5183
Relmada Therapeutics
RLMD
$527M
| $386K | ﹤0.01% |
128,800
-485
| -0.4% | -$1.75K |
|
5184
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $386K | ﹤0.01% |
1,290
+340
| +36% | +$111K |
|
5185
Ennis
EBF
$564M
| $385K | ﹤0.01% |
17,567
-19,116
| -52% | -$392K |
|
|
CEV
5186
Eaton Vance California Municipal Income Trust
CEV
$73.6M
| $384K | ﹤0.01% |
35,315
+2,673
| +8% | +$28.4K |
|
|
CVAC
5187
DELISTED
CureVac
CVAC
| $384K | ﹤0.01% |
112,972
-591,219
| -84% | -$1.93M |
|
5188
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$13.8M
| $383K | ﹤0.01% |
+3,169
| New | +$699K |
|
5189
Amplify BlueStar Israel Technology ETF
ITEQ
$119M
| $382K | ﹤0.01% |
8,337
+8,332
| +166,640% | +$376K |
|
5190
Icahn Enterprises
IEP
$5.3B
| $382K | ﹤0.01% |
23,191
+1,340
| +6% | +$22.7K |
|
|
MTAL
5191
DELISTED
Metals Acquisition
MTAL
| $382K | ﹤0.01% |
27,894
+20,443
| +274% | +$277K |
|
|
NAGE
5192
Niagen Bioscience
NAGE
$247M
| $382K | ﹤0.01% |
139,746
+119,723
| +598% | +$401K |
|
5193
Mesa Laboratories
MLAB
$574M
| $381K | ﹤0.01% |
4,396
-1,815
| -29% | -$190K |
|
5194
AllianzIM U.S. Equity Buffer20 Oct ETF
OCTW
$322M
| $381K | ﹤0.01% |
11,055
+6,704
| +154% | +$228K |
|
5195
TaskUs
TASK
$669M
| $381K | ﹤0.01% |
28,650
+3,459
| +14% | +$44.5K |
|
5196
Chegg
CHGG
$102M
| $380K | ﹤0.01% |
120,374
-202,159
| -63% | -$1M |
|
5197
United States Lime & Minerals
USLM
$3.44B
| $378K | ﹤0.01% |
5,190
-6,690
| -56% | -$446K |
|
5198
PUT
Compass
COMP
$9.66B
| $378K | ﹤0.01% |
105,000
+34,000
| +48% | +$125K |
|
5199
NETGEAR
NTGR
$635M
| $377K | ﹤0.01% |
24,665
-41,480
| -63% | -$580K |
|
5200
Ryanair
RYAAY
$31.3B
| $377K | ﹤0.01% |
8,095
+1,050
| +15% | +$54.6K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.